Sangathy
InternationalNews

Zydus begins human trials for potential coronavirus vaccine

Zydus has said it has started human studies for its potential coronavirus vaccine. In its human trials, Zydus will enrol over 1,000 subjects.

(Reuters illustration)

Indian pharmaceutical company Zydus said on Wednesday it has started human studies for its potential COVID-19 vaccine, as coronavirus infections continue to surge in the world’s third worst-hit nation.

ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic and well-tolerated in the pre-clinical toxicity studies, Zydus said.

In the human trials, Zydus will enrol over 1,000 subjects across multiple clinical study sites in India.

Related posts

களஞ்சியசாலையில் தீ விபத்து – இருவர் உயிரிழப்பு

Lincoln

Showers above 50mm in Western, North-western, Southern and Sabaragamuwa provinces and in Kandy and Nuwara-Eliya districts

Lincoln

USD 2.9bn IMF loan facility: Govt. confident of completing process early next year

Lincoln

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy